Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 199-218
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.199
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.199
Classification | Rifaximin | Rifaximin + antibiotics | ||||
Before | After | P value | Before | After | P value | |
g_Lactobacillus | 1.924 | 3.903 | 0.791 | 0.581 | 2.535 | 0.547 |
g_Bifidobacterium | 12.567 | 21.949 | 0.301 | 5.036 | 9.524 | 0.641 |
s_Faecalibacterium_prausnitzii | 10.448 | 8.193 | 0.910 | 6.590 | 3.206 | 0.148 |
- Citation: Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.199